Items where authors include "Collins, GP"

Article

Davies, AJ, Barrans, S, Stanton, L et al. (20 more authors) (2023) Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of Clinical Oncology, 41 (15). pp. 2718-2723. ISSN 0732-183X

Várnai, C, Palles, C, Arnold, R et al. (17 more authors) (2022) Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19. JAMA Network Open, 5 (2). e220130. ISSN 2574-3805

Booth, S, Curley, HM, Varnai, C et al. (33 more authors) (2022) Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. British Journal of Haematology, 196 (4). pp. 892-901. ISSN 0007-1048

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045